1118 Results for "

39

" in MedChemExpress (MCE) Product Catalog:
Products (1118)

1118 Results for "39" in MCE Product Catalog:

84
84 Publications Verification
Cat. No.: HY-15777
CAS No.: 1211441-98-3
Purity:  99.94%
Synonyms: LEE011
Target:  

CDK

Research Areas:  

Neurological Disease Cancer

RRibociclib (LEE011) is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
84
84 Publications Verification
Cat. No.: HY-15777A
CAS No.: 1211443-80-9
Purity:  99.93%
Synonyms: LEE011 hydrochloride
Target:  

CDK

Research Areas:  

Neurological Disease Cancer

RRibociclib (LEE011) hydrochloride is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
84
84 Publications Verification
Cat. No.: HY-15777B
CAS No.: 1374639-75-4
Purity:  99.93%
Synonyms: LEE011 succinate
Target:  

CDK

Research Areas:  

Neurological Disease Cancer

RRibociclib (LEE011) succinate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
84
84 Publications Verification
Cat. No.: HY-15777C
CAS No.: 1374639-79-8
Purity:  99.94%
Synonyms: LEE011 succinate hydrate
Target:  

CDK

Research Areas:  

Cancer

RRibociclib (LEE011) succinate hydrate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
70
70 Cited Publications
Cat. No.: HY-13443
CAS No.: 141758-74-9
Purity:  99.95%
Synonyms: Exenatide
Target:  

GCGR

Exendin-4 (Exenatide), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM.
loading...
    loading...
70
70 Cited Publications
Cat. No.: HY-13443A
CAS No.: 914454-01-6
Purity:  99.91%
Synonyms: Exenatide acetate
Target:  

GCGR

Exendin-4 acetate (Exenatide acetate), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM.
loading...
    loading...
69
69 Cited Publications
Cat. No.: HY-B0589
CAS No.: 134523-00-5
Atorvastatin is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively .
loading...
    loading...
69
69 Cited Publications
Cat. No.: HY-17379
CAS No.: 134523-03-8
Synonyms: CI-981; Atorvastatin hemicalcium
Atorvastatin hemicalcium salt (CI-981) is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, with blood-brain barrier permeability. Atorvastatin hemicalcium salt has the ability to effectively decrease blood lipids. Atorvastatin hemicalcium salt inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively .
loading...
    loading...
67
67 Cited Publications
Cat. No.: HY-108257
CAS No.: 134523-01-6
Purity:  99.76%
Atorvastatin sodium is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin sodium inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively .
loading...
    loading...
67
67 Cited Publications
Cat. No.: HY-B0589E
CAS No.: 344920-08-7
Atorvastatin hemicalcium trihydrate is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin hemicalcium trihydrate inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively .
loading...
    loading...
61
61 Cited Publications
Cat. No.: HY-15989
CAS No.: 957135-43-2
Target:  

IAP Apoptosis

Research Areas:  

Cancer

SM-164 is a cell-permeable Smac mimetic compound. SM-164 binds to XIAP protein containing both the BIR2 and BIR3 domains with an IC50 value of 1.39 nM and functions as an extremely potent antagonist of XIAP.
loading...
    loading...
61
61 Cited Publications
Cat. No.: HY-15989A
CAS No.: 2734174-02-6
Target:  

IAP Apoptosis

Research Areas:  

Cancer

SM-164 hydrochloride is a cell-permeable Smac mimetic compound. SM-164 binds to XIAP protein containing both the BIR2 and BIR3 domains with an IC50 value of 1.39 nM and functions as an extremely potent antagonist of XIAP.
loading...
    loading...
45
45 Cited Publications
Cat. No.: HY-P0264
CAS No.: 133514-43-9
Synonyms: Avexitide
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Exendin(9-39) amide (Avexitide) is a glucagon-like peptide-1 (GLP-1) antagonist that competes with endogenous GLP-1 for binding to GLP-1 receptors, thereby antagonizing the effects of excess GLP-1 secretion. Exendin(9-39) amide can be used to study postoperative hypoglycemia (PBH) .
loading...
    loading...
45
45 Cited Publications
Cat. No.: HY-P0264A
CAS No.: 2051593-46-3
Synonyms: Avexitide acetate
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Exendin(9-39) amide (Avexitide) acetate is a glucagon-like peptide-1 (GLP-1) antagonist that competes with endogenous GLP-1 for the GLP-1R, counteracting the effects of excessive GLP-1 secretion. Exendin(9-39) amide acetate can be utilized in Postbariatric hypoglycemia (PBH) research .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-W013332
CAS No.: 6736-58-9
3-Deazaadenosine is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 μM; 3-Deazaadenosine has anti-inflammatory, anti-proliferative and anti-HIV activity.
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-W013332A
CAS No.: 86583-19-9
3-Deazaadenosine (hydrochloride) is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 μM; 3-Deazaadenosine has anti-inflammatory, anti-proliferative and anti-HIV activity.
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-50752
CAS No.: 209984-57-6
Research Areas:  

Neurological Disease

LY-411575 is a potent γ-secretase inhibitor with IC50 of 0.078 nM/0.082 nM (membrane/cell-based), and also inhibits Notch S3 cleavage with an IC50 of 0.39 nM.
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-B1205
CAS No.: 51-55-8
Synonyms: Tropine tropate; DL-Hyoscyamine
Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-B0394
CAS No.: 5908-99-6
Synonyms: Tropine tropate sulfate monohydrate; DL-Hyoscyamine sulfate monohydrate
Target:  

mAChR

Atropine (Tropine tropate) sulfate monohydrate is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine sulfate monohydrate inhibits ACh-induced relaxations in human pulmonary veins. Atropine sulfate monohydrate can be used for research of anti-myopia and bradycardia .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-B1205A
CAS No.: 55-48-1
Synonyms: Tropine tropate sulfate; DL-Hyoscyamine sulfate; Sulfatropinol
Target:  

mAChR

Atropine (Tropine tropate) sulfate is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine sulfate inhibits ACh-induced relaxations in human pulmonary veins. Atropine sulfate can be used for research of anti-myopia and bradycardia .
loading...
    loading...